Patent Assignment
Reel/Frame 016722/0746
Release of Security Interest
Recorded: 2005-11-04
Pages: 39
Assignor
BANK OF AMERICA, N.A.
Executed: 2005-10-26
Assignees
ALPHARMA INC.
ONE EXECUTIVE DRIVE, FORT LEE, NEW JERSEY, 07024
ALPHARMA USPD INC.
10065 RED RUN BOULEVARD, OWINGS MILLS, MARYLAND, 21117
PARMED PHARMACEUTICALS, INC.
4220 HYDE PARK BOULEVARD, NIAGARA FALLS, NEW YORK, 14305
ALPHARMA ANIMAL HEALTH COMPANY
ONE EXECUTIVE DRIVE, FORT LEE, NEW JERSEY, 07024
MIKJAN CORPORATION
ONE EXECUTIVE DRIVE, FORT LEE, NEW JERSEY, 07024
Covered Properties
(18)
Antibiotic X-14868A,B,C and D
Patent:
4,278,663 →
Application:
06/116,696 →
Acylated Laidlomycin Derivatives
Patent:
4,431,665 →
Application:
06/162,473 →
Process for Producing Antibiotic X-14868A
Patent:
4,407,946 →
Application:
06/313,849 →
Controlling Nematodes in Animals and Soil with Nematocidal Antibiotics
Patent:
4,510,134 →
Application:
06/376,046 →
Process for the Preparation of Medicated Animal Feed Supplement
Patent:
4,447,421 →
Application:
06/482,271 →
Methods and Compositions for Treating Protozoal Infections with a Novel Antibiotic
Patent:
4,649,143 →
Application:
06/593,152 →
Novel Non-Dusting Antibiotic, Anticoccidial Premix Compositions and a Process for Their Manufacture
Patent:
4,824,829 →
Application:
06/750,144 →
Method for the Preparation of Feed Premix in Compositions of Maduramicin
Patent:
4,816,480 →
Application:
07/049,053 →
Live Vaccine for Coccidiosis Utilizing Coccidial Sporozoites
Patent:
4,808,404 →
Application:
07/141,953 →
Live Vaccine for Coccidiosis Utilizing Coccidial Sporozoites
Patent:
5,068,104 →
Application:
07/226,894 →
Recombinant Mva Vaccinia Virus
Patent:
5,185,146 →
Application:
07/293,738 →
Stable Antibiotic Ester Feed Compositions
Patent:
5,152,995 →
Application:
07/420,969 →
Cryptosporidiosis Amelioration
Patent:
5,200,418 →
Application:
07/728,875 →
Coccidiosis Vaccines
Patent:
5,403,581 →
Application:
07/729,099 →
Recombinant Coccidiosis Vaccines
Patent:
5,661,015 →
Application:
07/812,349 →
Coccidiosis Vaccines
Patent:
5,688,513 →
Application:
08/257,392 →
Suspension of Substantially Water-Insoluble Drugs and Methods of Their Manufacture
Patent:
5,712,310 →
Application:
08/664,338 →
Dna Encoding Eimeria Antigen
Patent:
6,008,342 →
Application:
08/770,035 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 18, 1994
From: A.H. ROBINS COMPANY, INC.
To: HOFFMANN-LA ROCHE INC.
Reel/Frame 006998/0462 →
Assignment of Assignor's Interest
Aug 14, 1995
From: AMERICAN CYANAMID COMPANY
To: HOFFMANN-LA ROCHE INC.
Reel/Frame 007596/0293 →
Assignment of Assignor's Interest
Jan 10, 1997
From: HOFFMANN-LA ROCHE INC.
To: ROCHE VITAMINS INC.
Reel/Frame 008366/0982 →
Assignment of Assignor's Interest
Jan 10, 1997
From: HOFFMANN-LA ROCHE INC.
To: ROCHE VITAMINS INC.
Reel/Frame 008322/0241 →
Assignment of Assignor's Interest
May 20, 1998
From: RHONE-POULENC INC.
To: ALPHARMA INC.
Reel/Frame 009197/0943 →
Assignment of Assignor's Interest
Oct 15, 1998
From: HOFFMANN-LA ROCHE INC.
To: ROCHE VITAMINS INC.
Reel/Frame 009525/0837 →
Assignment of Assignor's Interest
Jan 29, 2001
From: ROCHE VITAMINS INC.
To: ALPHARMA INC.
Reel/Frame 011485/0167 →
Merger
Apr 25, 2001
From: SYNTEX (U.S.A.) INC.
To: SYNTEX (U.S.A.) LLC
Reel/Frame 011751/0360 →
Merger
Apr 25, 2001
From: SYNTEX (U.S.A.) INC.
To: SYNTEX (U.S.A.) LLC
Reel/Frame 011751/0352 →
Assignment of Assignor's Interest
Sep 21, 2001
From: SYNTEX (U.S.A.) LLC.
To: ALPHARMA INC.
Reel/Frame 011987/0642 →
Assignment of Assignor's Interest
Sep 21, 2001
From: SYNTEX (U.S.A.) LLC.
To: ALPHARMA INC.
Reel/Frame 011987/0425 →
Security Interest
Dec 18, 2001
From: ALPHARMA INC.; ALPHARMA USPD INC.; PARMED PHARMACEUTICALS, INC.; ALPHARMA ANIMAL HEALTH COMPANY
To: BANK OF AMERICA, N.A.
Reel/Frame 012365/0299 →
Security Agreement
Nov 10, 2005
From: PARMED PHARMACEUTICALS, INC.
To: BANK OF AMERICA, N.A., AS AGENT
Reel/Frame 016761/0709 →
Security Agreement
Nov 10, 2005
From: ALPHARMA USPD INC.
To: BANK OF AMERICA, N.A., AS AGENT
Reel/Frame 016761/0718 →
Security Agreement
Nov 21, 2005
From: ALPHARMA INC.
To: BANK OF AMERICA, N.A., AS AGENT
Reel/Frame 016800/0358 →
Release of Security Interest
Jun 12, 2006
From: BANK OF AMERICA, N.A.
To: ALPHARMA USPD INC.
Reel/Frame 017759/0871 →
Grant of Security Interest
Nov 28, 2007
From: ACTAVIS MID ATLANTIC LLC, A LIMITED LIABILITY COMPANY
To: DEUTSCHE BANK AG, LONDON BRANCH, AS SECURITY AGENT
Reel/Frame 020540/0435 →
Merger
Dec 6, 2007
From: ALPHARMA USPD INC.
To: ACTAVIS MID ATLANTIC LLC
Reel/Frame 020234/0565 →
Security Agreement
Dec 30, 2008
From: ALPHARMA, INC.
To: CREDIT SUISSE, AS AGENT
Reel/Frame 022034/0941 →
Release of Security Interest in Patents
Jan 13, 2009
From: BANK OF AMERICA, NA
To: ALPHARMA, INC.
Reel/Frame 022092/0670 →
Release of Security Interest
May 11, 2010
From: ALPHARMA, LLC [F/K/A ALPHARMA, INC.]
To: CREDIT SUISSE AG
Reel/Frame 024369/0068 →
Security Agreement
May 14, 2010
From: ALPHARMA, LLC
To: CREDIT SUISSE AG
Reel/Frame 024386/0963 →
Patent Security Agreement Supplement
Dec 10, 2010
From: ACTAVIS GROUP HF.
To: DEUTSCHE BANK AG, LONDON BRANCH
Reel/Frame 025468/0833 →
Release of Security Interest
Feb 2, 2011
From: CREDIT SUISSE AG
To: ALPHARMA, LLC
Reel/Frame 025735/0359 →
Release of Security Interest in Intellectual Property
Nov 1, 2012
From: DEUTSCHE BANK AG, LONDON BRANCH
To: ACTAVIS MID ATLANTIC LLC
Reel/Frame 029229/0972 →